BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 765143)

  • 21. Restorative effects of thymosin polypeptides on purified protein derivative--dependent migration inhibition factor production by the peripheral blood lymphocytes of adult thymectomized guinea pigs.
    Thurman GB; Seals C; Low TL; Goldstein AL
    J Biol Response Mod; 1984; 3(2):160-73. PubMed ID: 6374044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphokines. II. Use of horse monocytes as indicator cells for human MIF.
    Friedrich W; Lazary S; de Weck AL
    Int Arch Allergy Appl Immunol; 1976; 50(2):142-54. PubMed ID: 1107231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro responses of cats sensitized with viable Mycobacterium bovis (BCG).
    Legendre AM; Easley JR; Becker PU
    Am J Vet Res; 1979 Nov; 40(11):1613-9. PubMed ID: 393146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Destruction of syngeneic tumors by tuberculin-stimulated peritoneal exudate cells from guinea pigs immunized to Mycobacterium bovis (strain BCG).
    Zwilling BS; Leonard EJ; Bast RC; Zbar B
    J Natl Cancer Inst; 1974 Aug; 53(2):541-6. PubMed ID: 4367248
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune mechanisms affecting bovine leucocytes during suppression of tuberculin skin sensitivity in cattle.
    Corner LA; Outteridge PM; Pearson W; Lepper AW
    Int Arch Allergy Appl Immunol; 1976; 52(1-4):3-14. PubMed ID: 797673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation-inducing factors from human lymphocytes. Correlation with polymorphonuclear leucocyte migration enhancement of inhibition.
    Warrington RJ; Buehler SK; Roberts KB
    Int Arch Allergy Appl Immunol; 1976; 51(2):186-97. PubMed ID: 1279021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous generation of tuberculin-type and cutaneous basophilic hypersensitivity at separate sites in the guinea pig.
    Leonard EJ; Lett-Brown MA; Askenase PW
    Int Arch Allergy Appl Immunol; 1979; 58(4):460-9. PubMed ID: 374281
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovis (strain BCG).
    Zbar B; Bernstein I; Tanaka T; Rapp HJ
    Science; 1970 Dec; 170(3963):1217-8. PubMed ID: 4920656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between 'sensitized lymphocytes' and antigen in vitro. I. The release of a skin reactive factor.
    Pick E; Krejci J; Cech K; Turk JL
    Immunology; 1969 Nov; 17(5):741-67. PubMed ID: 4187522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mechanism of migration inhibition involving components of the coagulation system.
    Meade CJ; Lachmann PJ; Binns RM
    Scand J Immunol; 1976; 5(5):529-39. PubMed ID: 785591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination.
    Tree JA; Elmore MJ; Javed S; Williams A; Marsh PD
    Infect Immun; 2006 Feb; 74(2):1436-41. PubMed ID: 16428800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-specific release of migration inhibitory factor by senescent immune lung cells in aged guinea pigs.
    Ganguly R
    Adv Exp Med Biol; 1987; 216B():1417-20. PubMed ID: 3321937
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of migration inhibiting factor(s) on the in vitro detachment of macrophages.
    Weiss L; Glaves D
    J Immunol; 1975 Nov; 115(5):1362-5. PubMed ID: 1100729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte migration inhibition of tumor antigen and purified protein derivative reactivity in guinea pigs sensitized to line 10 hepatocarcinoma and BCG.
    McCoy JL; Brandhorst J; Hanna MG
    J Natl Cancer Inst; 1978 Mar; 60(3):693-9. PubMed ID: 75270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STUDIES ON THE EARLY CHANGES OF TION IN VITRO OF PERITONEAL EXUDATE CELLS FROM GUINEA PIGS AT DIFFERENT LEVELS AFTER INFECTION WITH MYCOBACTERIUM TUBERCULOSIS.
    SCHWEIGER O; TOMCSANYI A; LOEW B
    Am Rev Respir Dis; 1964 Mar; 89():429-34. PubMed ID: 14129345
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of species specificity of a skin-reactive factor released from sensitized guinea pig spleen cells.
    Yoshida T; Nagai R; Hashimoto T
    Lab Invest; 1973 Sep; 29(3):329-35. PubMed ID: 4598145
    [No Abstract]   [Full Text] [Related]  

  • 38. Process of the tuberculin reaction and the complement fixation reaction of the BCG inoculated guinea pig after its tuberculous infection.
    SHIMIZU T
    Kekkaku; 1950 May; 25(5):198-203. PubMed ID: 14779397
    [No Abstract]   [Full Text] [Related]  

  • 39. A new lymphocyte proliferation assay for potency determination of bovine tuberculin PPDs.
    Spohr C; Kaufmann E; Battenfeld S; Duchow K; Cussler K; Balks E; Bastian M
    ALTEX; 2015; 32(3):201-10. PubMed ID: 25935213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of antigenic fractions of tuberculin.
    Tuboly S; Szent-Iványi T
    Acta Microbiol Acad Sci Hung; 1976; 23(1):23-8. PubMed ID: 59518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.